Cite
HARVARD Citation
Vansteenkiste, J. et al. (2019). Current status of immune checkpoint inhibition in early-stage NSCLC. Annals of oncology. pp. 1244-1253. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Vansteenkiste, J. et al. (2019). Current status of immune checkpoint inhibition in early-stage NSCLC. Annals of oncology. pp. 1244-1253. [Online].